Group 1 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash purchase and capital increase, aiming for rapid capacity expansion to meet growing downstream demand [2] - Huiru Technology specializes in the R&D, production, and sales of high-performance electrolytic copper foil, with a current production capacity of 20,000 tons per year [2] - East China Pharmaceutical's subsidiary, Daor Biotechnology, has its product DR10624 included in the list of breakthrough therapeutic varieties, targeting severe hypertriglyceridemia [3][18] - DR10624 is a globally first-of-its-kind long-acting tri-specific agonist, showing excellent efficacy in reducing triglycerides and eliminating liver fat in clinical trials [3][18] Group 2 - Xiantan Co. reported a 9.41% year-on-year increase in chicken product sales revenue, reaching 529 million yuan, with sales volume up by 6.76% [4][19] - Jiamei Packaging's stock will resume trading on January 12 after completing a review during its suspension, with a significant price increase of 230.48% during the suspension period [5][20] - Xianle Health plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange, considering the interests of existing shareholders [6][21][22] Group 3 - China Shipbuilding Defense expects a net profit increase of 149.61% to 196.88% for 2025, projecting a profit of 940 million to 1.12 billion yuan [7][23] - Daotong Technology anticipates a net profit growth of 40.42% to 45.10% for 2025, with a projected profit of 900 million to 930 million yuan [8][24] - Huace Navigation forecasts a net profit increase of 14.84% to 18.27% for 2025, estimating a profit of 670 million to 690 million yuan [9][25] Group 4 - Luokai Co. won a procurement project from State Grid Fujian Electric Power, with a total contract value of approximately 48.2 million yuan [10][26] - Minhe Co. reported a 65.22% year-on-year increase in the sales volume of commodity broiler chicks, totaling approximately 29.66 million chicks, with sales revenue up by 53.09% [11][27] - Zhenghai Bio obtained a medical device registration certificate for calcium silicate bio-ceramic oral bone repair materials, suitable for alveolar bone defect repair [12][28] - Three Gorges Energy reported a cumulative total power generation increase of 5.99% for 2025, with a total generation of 762.61 billion kWh [13][29] - Huisheng Bio expects a net profit of 235 million to 271 million yuan for 2025, marking a turnaround from a loss in the previous year [14][30]

证券日报网讯1月11日，仙坛股份（002746）发布公告称，公司2025年12月鸡肉产品销售收入52， 963.33万元、销量5.51万吨，同比增长9.41%、6.76%，环比增长7.29%、降低4.04%。 ...

Company Performance - Xiantan Co., Ltd. reported a chicken product sales revenue of 530 million yuan for December 2025, with a year-on-year growth of 9.41% and a month-on-month growth of 7.29% [1] - The total sales volume for chicken products reached 55,100 tons, reflecting a year-on-year increase of 6.76% and a month-on-month decrease of 4.04% [1] Poultry Farming and Processing Industry - The poultry farming and processing sector achieved a sales revenue of 472 million yuan, with a year-on-year growth of 4.76% and a month-on-month growth of 9.56% [1] - The sales volume in this sector was 51,200 tons, showing a year-on-year increase of 4.07% and a month-on-month decrease of 3.08% [1] Food Processing Industry - The food processing industry generated a sales revenue of approximately 57.66 million yuan, with a significant year-on-year growth of 71.83% and a year-on-year sales volume increase of 63.04% [1] - However, the month-on-month sales revenue and volume experienced declines of 8.28% and 15.36%, respectively [1]

Group 1 - Jia Mei Packaging's stock will resume trading on January 12, 2026, after completing a review due to a 230.48% price increase from December 17, 2025, to January 6, 2026 [1] - Yan Jiang Co. continues to suspend trading as it plans to acquire assets, with a disclosure expected by January 19, 2026 [2] - Defu Technology terminated its acquisition of 100% of Luxembourg Copper Foil due to restrictions from the Luxembourg Ministry of Economy, with a refund of €17.4047 million expected [3] Group 2 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash and capital increase, with Huiru focusing on high-performance electrolytic copper foil [4] - Shangluo Electronics' application for issuing convertible bonds has been accepted by the Shenzhen Stock Exchange [5] - Xianle Health intends to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [6] Group 3 - Hangyu Technology plans to sell up to 752,800 repurchased shares to supplement working capital, with a potential cancellation of unsold shares [7] - Fangsheng Pharmaceutical's production facility failed a GMP compliance check, but it will not significantly impact operations [8][9] - East China Pharmaceutical's subsidiary's product has been included in the list of breakthrough therapeutic varieties for severe hypertriglyceridemia [10] Group 4 - Dechang Co. expects a net profit decrease of 51% to 61% for 2025, primarily due to competitive pressures and foreign exchange losses [12] - Hebang Bio anticipates a net loss for 2025 due to asset impairment provisions [13] - Qu Mei Home expects a net loss for 2025, with significant negative figures reported for the first nine months [14] Group 5 - Jinzongzi Wine forecasts a net loss for 2025, although the loss is expected to narrow compared to the previous year [15] - Sichuan Electronics expects a net loss of between 265 million to 340 million yuan for 2025, attributed to market competition and delayed orders [16] - Wansheng Co. anticipates a net loss for 2025 [17] - Weiyuan Co. also expects a net loss for 2025 [19] - Kosen Technology predicts a net loss for 2025 due to low capacity utilization and strategic adjustments [20] - Zhongheng Group expects a net loss for 2025 [21] Group 6 - Xiantan Co. reported a 9.41% year-on-year increase in chicken product sales revenue to 530 million yuan in December 2025 [22] Group 7 - Huate Gas shareholders plan to reduce their holdings by up to 2% through block trades [24] - Meidike shareholders plan to reduce their holdings by up to 1% through market transactions [25]

Company Performance - Xiantan Co., Ltd. reported chicken product sales revenue of 529.63 million yuan for December 2025, with a year-on-year growth of 9.41% and a month-on-month growth of 7.29% [1] - The total sales volume for chicken products reached 55,100 tons, reflecting a year-on-year increase of 6.76% and a month-on-month decrease of 4.04% [1] Industry Breakdown - The poultry farming and processing sector generated chicken product sales revenue of 471.97 million yuan, with a year-on-year growth of 4.76% and a month-on-month growth of 9.56% [1] - The sales volume in this sector was 51,200 tons, showing a year-on-year increase of 4.07% and a month-on-month decrease of 3.08% [1] - The food processing industry achieved chicken product sales revenue of 57.66 million yuan, with a significant year-on-year growth of 71.83% and a sales volume of 3,800 tons, reflecting a year-on-year increase of 63.04% [1] - However, the food processing sector experienced a month-on-month decline in sales revenue by 8.28% and a decrease in sales volume by 15.36% [1]

Core Viewpoint - Xiantan Co., Ltd. (002746.SZ) reported a chicken product sales revenue of 530 million yuan for December 2025, with a sales volume of 55,100 tons, reflecting year-on-year changes of 9.41% and 6.76%, and quarter-on-quarter changes of 7.29% and -4.04% [1] Group 1: Poultry Farming and Processing Industry - The poultry farming and processing sector achieved chicken product sales revenue of 472 million yuan and a sales volume of 51,200 tons, with year-on-year changes of 4.76% and 4.07%, and quarter-on-quarter changes of 9.56% and -3.08% [1] - The pre-offset chicken product sales revenue was 514 million yuan, with a sales volume of 54,300 tons [1] Group 2: Food Processing Industry - The food processing sector reported chicken product sales revenue of 57.66 million yuan and a sales volume of 3,800 tons, with year-on-year changes of 71.83% and 63.04%, and quarter-on-quarter changes of -8.28% and -15.36% [1]

Core Viewpoint - Xiantan Co., Ltd. reported a chicken product sales revenue of 530 million yuan for December 2025, with a sales volume of 55,100 tons, reflecting year-on-year changes of 9.41% and 6.76%, and quarter-on-quarter changes of 7.29% and -4.04% respectively [1] Group 1: Poultry Farming and Processing Industry - The poultry farming and processing industry achieved chicken product sales revenue of 472 million yuan and a sales volume of 51,200 tons, with year-on-year changes of 4.76% and 4.07%, and quarter-on-quarter changes of 9.56% and -3.08% respectively [1] - The pre-offset chicken product sales revenue was 514 million yuan, with a sales volume of 54,300 tons [1] Group 2: Food Processing Industry - The food processing industry generated chicken product sales revenue of 57.66 million yuan and a sales volume of 3,800 tons, with year-on-year changes of 71.83% and 63.04%, and quarter-on-quarter changes of -8.28% and -15.36% respectively [1]

其中，家禽饲养加工行业实现鸡肉产品销售收入4.72亿元，销售数量5.12万吨(注：抵消前的鸡肉产品销 售收入为5.14亿元，销售数量5.43万吨)，同比变动4.76%、4.07%，环比变动9.56%、-3.08%;食品加工行 业实现鸡肉产品销售收入5,765.88万元，销售数量0.38万吨，同比变动71.83%、63.04%，环比变 动-8.28%、-15.36%。 智通财经APP讯，仙坛股份(002746.SZ)发布公告，公司2025年12月实现鸡肉产品销售收入5.3亿元，销 售数量5.51万吨，同比变动幅度分别为9.41%、6.76%，环比变动幅度分别为7.29%、-4.04%。 ...

一、2025 年 12 月份销售情况简报 山东仙坛集团股份有限公司（以下简称"公司"）2025 年 12 月实现鸡肉产品 销售收入 52,963.33 万元，销售数量 5.51 万吨，同比变动幅度分别为 9.41%、 6.76%，环比变动幅度分别为 7.29%、-4.04%。 其中，家禽饲养加工行业实现鸡肉产品销售收入 47,197.45 万元，销售数量 5.12 万吨（注：抵消前的鸡肉产品销售收入为 51,428.34 万元，销售数量 5.43 万吨），同比变动 4.76%、4.07%，环比变动 9.56%、-3.08%；食品加工行业实现 鸡肉产品销售收入 5,765.88 万元，销售数量 0.38 万吨，同比变动 71.83%、 63.04%，环比变动-8.28%、-15.36%。 上述数据未经审计，与定期报告披露的数据之间可能存在差异。因此上述数 据仅作为阶段性数据供投资者参考。 二、原因说明 证券代码：002746 证券简称：仙坛股份 公告编号：2026-001 山东仙坛集团股份有限公司 2025 年 12 月份销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误 ...

每经AI快讯，1月11日，仙坛股份（002746）(002746.SZ)公告称，公司2025年12月实现鸡肉产品销售收 入5.3亿元，销售数量5.51万吨，同比变动分别为9.41%和6.76%。 ...